Literature DB >> 9550326

Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.

A Wölpl1, T Halder, H Kalbacher, H Neumeyer, K Siemoneit, S F Goldmann, T H Eiermann.   

Abstract

Alloreactive T cells recognize peptides presented in the binding groove of major histocompatibility complex molecules (MHCs), whereas B cells mainly recognize the MHCs independent of bound peptides. Here, we demonstrate that the human B-cell repertoire comprises B cells which can be stimulated during pregnancy to produce antibodies reacting with MHCs in a way similar to T cells. The human monoclonal antibody UL-5A1 recognizes DR1(DRA/DRB1*0101) molecules on lymphoblastoid cell lines only if they co-express HLA-A2 or if they have been loaded with HLA-A2-derived peptides. The effect of the HLA-A2 peptide 105-117 on UL-5A1 reactivity was specific, time and dose-dependent. Reactivity increased when naturally processed peptides were removed from DR1 molecules before the HLA-A2 peptide 105-117 was loaded. UL-5A1 reacted specifically with cells that had been activated. The results imply a role of activation of cells in peptide processing and/or loading.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9550326     DOI: 10.1111/j.1399-0039.1998.tb03100.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

1.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

2.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

3.  Elevated serum levels of B-cell activating factor in pediatric renal transplant patients.

Authors:  Anja Lehnhardt; Franziska Dunst; Michael van Husen; Sebastian Loos; Jun Oh; Thomas Eiermann; Martina Koch; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2012-03-28       Impact factor: 3.714

4.  Functional HLA-DM on the surface of B cells and immature dendritic cells.

Authors:  S O Arndt; A B Vogt; S Markovic-Plese; R Martin; G Moldenhauer; A Wölpl; Y Sun; D Schadendorf; G J Hämmerling; H Kropshofer
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

5.  A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

Authors:  Suzanne Bezstarosti; Kim H Bakker; Cynthia S M Kramer; Johan W de Fijter; Marlies E J Reinders; Arend Mulder; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

Review 6.  TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review.

Authors:  Ying Li; Wei Jiang; Elizabeth D Mellins
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

7.  Efficient generation of monoclonal antibodies against peptide in the context of MHCII using magnetic enrichment.

Authors:  Justin A Spanier; Daniel R Frederick; Justin J Taylor; James R Heffernan; Dmitri I Kotov; Tijana Martinov; Kevin C Osum; Jenna L Ruggiero; Blake J Rust; Samuel J Landry; Marc K Jenkins; James B McLachlan; Brian T Fife
Journal:  Nat Commun       Date:  2016-06-13       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.